Oral Abstract Session
Hypertension and Cardiorenal Disease: Novel Mechanisms and Therapeutic Targets
November 07, 2025 | 04:30 PM - 06:00 PM
Location: Room 332A, Convention Center
Session Description
Oral Abstract Session
Note: Continuing education credits are not being offered for this session.
Learning Pathway(s)
- Hypertension and Cardiorenal Disorders
Moderators
Presentations
- Self-Monitoring and Self-Management of Hypertension in US Veterans: A Randomized Controlled Trial
04:30 PM - 04:40 PM
- Exosomes as Mediators of Cardiomyocyte Injury and Heart Failure in Experimental Glomerular Disease
04:40 PM - 04:50 PM
- Sustained Blood Pressure Reduction Following Ultrasound Renal Denervation in Patients with CKD: 12-Month Follow-Up Data from the RDN-CKD Study
04:50 PM - 05:00 PM
- Individualized Net Benefit of Intensive Blood Pressure Lowering Among Persons with CKD in SPRINT
05:00 PM - 05:10 PM
- Attitudes and Perception of Artificial Intelligence in Hypertension: Cross-Sectional Survey Among Patients and Clinicians
05:10 PM - 05:20 PM
- Exercise Cardiac MRI and Cardiopulmonary Testing Reveal Distinct Exercise Phenotypes and Dynamic Cardiac Impairment in CKD: CRUISE-CKD Study
05:20 PM - 05:30 PM
- Risk-Based Stratification Approach for Cardiovascular-Kidney-Metabolic Syndrome Stage 2 Using a Simple Algorithm
05:30 PM - 05:40 PM
- Deletions of Npr1 in Nephron Tubule Cells Lead to Salt-Sensitive Hypertension and Kidney Dysfunction in Both Male and Female Mutant Mice
05:40 PM - 05:50 PM
- Dual SGLT1/2 Inhibition Attenuates Salt-Sensitive Hypertension and Kidney Injury More Effectively than SGLT2 Inhibition
05:50 PM - 06:00 PM